作者：
Marisol,Perez-Toledo [1]
;
Sian E,Faustini [1]
;
Sian E,Jossi [1]
;
Adrian M,Shields [1]
;
Edith,Marcial-Juarez [1]
;
Hari Krishnan,Kanthimathinathan [2]
;
Joel D,Allen [3]
;
Yasunori,Watanabe [4]
;
Margaret,Goodall [5]
;
Benjamin E,Willcox [1]
;
Carrie R,Willcox [1]
;
Mahboob,Salim [1]
;
David C,Wraith [1]
;
Tonny V,Veenith [1]
;
Eleni,Syrimi [6]
;
Mark T,Drayson [1]
;
Deepthi,Jyothish [1]
;
Eslam,Al-Abadi [7]
;
Ashish,Chikermane [2]
;
Steven B,Welch [8]
;
Kavitha,Masilamani [9]
;
Scott,Hackett [10]
;
Max,Crispin [7]
;
Barnaby R,Scholefield [11]
;
Adam F,Cunningham [4]
;
Alex G,Richter [3]
作者单位：
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
[1]
Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.
[2]
Paediatric Intensive Care Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
[3]
School of Biological Sciences, University of Southampton, Southampton, UK.
[4]
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK.
[5]
Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, Birmingham, UK.
[6]
Department of General Paediatrics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
[7]
Childhood Arthritis and Rheumatic Diseases Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
[8]
Department of Cardiology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
[9]
Department of Paediatrics, Birmingham Chest Clinic and Heartlands Hospital, University Hospitals Birmingham, Birmingham, UK.
[10]
West Midlands Immunodeficiency Centre, Heartlands Hospital, University Hospitals Birmingham, Birmingham, UK.
[11]
Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
[12]
DOI
10.1111/pai.13504
PMID
33724541
发布时间
2024-02-14
换一批
换一批
